Company intelligence / Profile preview

Zoëcon

Dallas, Texas, United Stateszoecon.com ↗

Ownership: Private
Development stage: Other

Overview

Zoëcon pioneered insect growth regulator technology for pest management. Its portfolio includes commercialized IGRs and combination products for professional pest control. No clinical results as it does not develop drugs for human use.

Modalities: Small molecule (insect growth regulators and insecticides)Botanical-based products
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Zoëcon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zoëcon.

Explore the full profile